Amgen Inc (AMGN)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ
Market Cap: $250.07B
Last updated: Nov 17, 2026 at 4:44 PM ET
Amgen Inc (AMGN) Stock Chart
Amgen (AMGN) has a latest price of $457.93 on Nov 17, 2026, 5.4% below its 52-week high of $483.99. Its price rose 37.9% over the past 12 months. The month-end price rose 230.1% over the 10 years through Oct 2026, a compound annual rate of 12.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $466.01 in Oct 2026 and its lowest $141.16 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart AMGN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for AMGN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 4.1%, and over 6 months it rose 39.2%. The month-end price rose 82.2% over the 3 years through Oct 2026, a compound annual rate of 22.1%.
| Period | Change |
|---|---|
| 1 month | +7.8% |
| 3 months | +4.1% |
| 6 months | +39.2% |
| 12 months | +37.9% |
| 12 months, with dividends | +40.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +82.2% | +22.1% |
| 5 years | +125.2% | +17.6% |
| 10 years | +230.1% | +12.7% |
Price by Year
Its best calendar year was 2025, when the price rose 25.6%, and its weakest was 2024, when it fell 9.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $466.01 | +42.4% |
| 2025 | $327.31 | +25.6% |
| 2024 | $260.64 | -9.5% |
| 2023 | $288.02 | +9.7% |
| 2022 | $262.64 | +16.7% |
| 2021 | $224.97 | -2.2% |
| 2020 | $229.92 | -4.6% |
| 2019 | $241.07 | +23.8% |
| 2018 | $194.67 | +11.9% |
| 2017 | $173.90 | +18.9% |
Trading Range
The price is 7.2% above its 50-day average of $427.10 and 20.5% above its 200-day average of $380.10.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $457.93 | |
| 52-week high | $483.99 | -5.4% |
| 52-week low | $306.13 | +49.6% |
| 50-day average | $427.10 | +7.2% |
| 200-day average | $380.10 | +20.5% |
Price Risk
Over 3 years, its largest fall from a peak was 22.7%.
| Measure | Value |
|---|---|
| 1-year beta | 0.50 |
| Largest fall, 1 year | -17.0% |
| Largest fall, 3 years | -22.7% |
Valuation
Amgen traded at 15.0x earnings at the end of 2025, against a 5-year median of 14.7x and a 10-year median of 14.3x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About AMGN
What is AMGN's 1-year price change?
Amgen's price rose 37.9% over the past 12 months. With dividends included, the 12-month total return was 40.9%.
What is AMGN's 5-year price change?
Amgen's month-end price rose 125.2% over the 5 years through Oct 2026, a compound annual rate of 17.6%. These figures leave out dividends.
What is AMGN's 52-week high and low?
Amgen's 52-week high is $483.99 and its 52-week low is $306.13. Its latest price of $457.93 on Nov 17, 2026 is 5.4% below the high.
What is AMGN's beta?
Amgen's 1-year beta against the S&P 500 is 0.50, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 17.0%.
Is the AMGN chart free?
Yes. Advanced Charting for AMGN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
AMGN pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts